PDP2 Activators
PDP2 activators encompass a diverse array of chemical compounds that collectively function to enhance the enzyme's dephosphorylation activity through various indirect biochemical pathways. Forskolin and Sildenafil both raise levels of cyclic nucleotides (cAMP and cGMP, respectively), with Forskolin acting via adenylate cyclase activation and Sildenafil inhibiting phosphodiesterase 5. The elevated cyclic nucleotides activate protein kinases A and G, which may phosphorylate proteins in a manner that supports PDP2's dephosphorylation activity. Similarly, Retinoic acid and Pioglitazone modulate nuclear receptor pathways (RAR and PPAR-gamma, respectively), potentially altering gene expression in a way that creates a favorable metabolic environment for PDP2 function. Oleic Acid, by changing membrane dynamics, and Curcumin, through AMPK activation, both may indirectly lead to an enhancement of PDP2's role in metabolism by affecting the cellular demand for its enzymatic activity.
Additionally, the activators such as Resveratrol and Nicotinamide influence PDP2 activity through modulation of sirtuin pathways, particularly SIRT1, which can alter protein function by deacetylation - this process could indirectly affect the substrates and interaction partners of PDP2, promoting its enzymatic action. Metformin and α-Ketoglutarate activate AMPK and support the Krebs cycle, respectively, both contributing toan adjustment in cellular energy homeostasis that could indirectly enhance PDP2's role in metabolic regulation. Lithium and Capric Acid further contribute to this regulatory network: Lithium through GSK-3 inhibition, potentially affecting proteins that are substrates of PDP2, and Capric Acid by altering the cellular metabolic state, which may increase the functional demand for PDP2 activity. Collectively, these PDP2 activators, through their targeted impact on cellular signaling and metabolism, facilitate an increase in the functional activity of PDP2 without directly.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels, which in turn can activate PKA. PKA phosphorylates various proteins that could enhance the dephosphorylation activity of PDP2 on its specific substrates. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates the retinoic acid receptor (RAR) signaling pathway which can influence cellular differentiation and metabolism, potentially creating a cellular environment that enhances PDP2 activity. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic Acid is a fatty acid that can alter cell membrane composition and fluidity, potentially affecting membrane-bound enzymes and receptors, leading to signaling changes that indirectly enhance PDP2 activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which can deacetylate proteins and affect their function. Through SIRT1 activation, the cellular environment may change in a way that enhances the metabolic functions of PDP2. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMPK, which is a key regulator of cellular energy homeostasis, potentially leading to an increase in PDP2 activity as the cell shifts toward catabolic metabolism. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 can lead to altered phosphorylation states of proteins that may indirectly increase PDP2 activity by affecting its substrates. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone is a PPAR-gamma agonist, modulating transcription of various genes involved in glucose and lipid metabolism, which may create a metabolic state that indirectly enhances PDP2 activity. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide is a precursor of NAD+, which is a coenzyme in redox reactions. Elevated NAD+ levels can enhance the deacetylase activity of SIRT1, potentially influencing PDP2 activity via metabolic modulation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to activate AMPK, which enhances cellular energy metabolism. Through AMPK activation, PDP2's role in metabolic processes could be indirectly enhanced. | ||||||
α-Ketoglutaric Acid | 328-50-7 | sc-208504 sc-208504A sc-208504B sc-208504C sc-208504D sc-208504E sc-208504F | 25 g 100 g 250 g 500 g 1 kg 5 kg 16 kg | $33.00 $43.00 $63.00 $110.00 $188.00 $738.00 $2091.00 | 2 | |
α-Ketoglutarate is an intermediate in the Krebs cycle and is involved in metabolic signaling. Supplementation may support a cellular environment that enhances PDP2's metabolic functions. | ||||||